Skip to main content
Journal ArticleOPEN ACCESS

Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention

  • Montalescot G
  • White H
  • Gallo R
  • et al.
New England Journal of Medicine (2006) 355(10) 1006-1017
DOI: 10.1056/nejmoa052711
342Citations
Citations of this article
134Readers
Mendeley users who have this article in their library.

Abstract

Despite its limitations, unfractionated heparin has been the standard anticoagulant used during percutaneous coronary intervention (PCI). Several small studies have suggested that intravenous enoxaparin may be a safe and effective alternative. Our primary aim was to assess the safety of enoxaparin as compared with that of unfractionated heparin in elective PCI.

Cite

CITATION STYLE

APA

Montalescot, G., White, H. D., Gallo, R., Cohen, M., Steg, P. G., Aylward, P. E. G., … Steinhubl, S. R. (2006). Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. New England Journal of Medicine, 355(10), 1006–1017. https://doi.org/10.1056/nejmoa052711

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free